NVDA
57
5
CB
48
2
WY
36
5
ADT
25
11
BF.B
33
-3
KMX
54
-10
BRK.B
22
5
CNP
52
-7
MDLZ
30
2
CHRW
51
-2
WBA
38
-3
ABBV
46
4
BSX
67
3
HAL
30
-10
MSFT
53
-2
BBY
46
-2
REGN
44
2
ADI
57
2
KSS
38
2
FFIV
63
2
NVDA
57
5
CB
48
2
WY
36
5
ADT
25
11
BF.B
33
-3
KMX
54
-10
BRK.B
22
5
CNP
52
-7
MDLZ
30
2
CHRW
51
-2
WBA
38
-3
ABBV
46
4
BSX
67
3
HAL
30
-10
MSFT
53
-2
BBY
46
-2
REGN
44
2
ADI
57
2
KSS
38
2
FFIV
63
2
Financhill
Back

Verona Pharma PLC Stock Price Chart

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
48

VRNA
Verona Pharma PLC

Last Price:
$45.02
Seasonality Move:
1.28%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRNA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Verona Pharma PLC Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 41.71 Buy
20-day SMA: 40.52 Buy
50-day SMA: 37.79 Buy
200-day SMA: 24.36 Buy
8-day EMA: 42.01 Buy
20-day EMA: 40.56 Buy
50-day EMA: 37.61 Buy
200-day EMA: 27.82 Buy

Verona Pharma PLC Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.47 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 672029 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.1 - 41.82) Buy
Bollinger Bands (100): (26.7 - 38.58) Buy

Verona Pharma PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Verona Pharma PLC Stock

Is Verona Pharma PLC Stock a Buy?

  • Verona Pharma PLC share price is 45.28 while VRNA 8-day simple moving average is 41.71, which is a Buy signal.
  • The stock price of VRNA is 45.28 while Verona Pharma PLC 20-day SMA is 40.52, which makes it a Buy.
  • Verona Pharma PLC 50-day simple moving average is 37.79 while VRNA share price is 45.28, making it a Buy technically.
  • VRNA stock price is 45.28 and Verona Pharma PLC 200-day simple moving average is 24.36, creating a Buy signal.

VRNA Technical Analysis vs Fundamental Analysis

Sell
48
Verona Pharma PLC (VRNA) is a Sell

Is Verona Pharma PLC a Buy or a Sell?

  • Verona Pharma PLC stock is rated a Sell
    The current Verona Pharma PLC [VRNA] share price is $45.28. The Score for VRNA is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.

Verona Pharma PLC Stock Info

Market Cap:
3.7B
Price in USD:
45.28
Share Volume:
1M

Verona Pharma PLC 52-Week Range

52-Week High:
45.98
52-Week Low:
11.39
Sell
48
Verona Pharma PLC (VRNA) is a Sell

Verona Pharma PLC Share Price Forecast

Is Verona Pharma PLC Stock a Buy?

  • Verona Pharma PLC share price is 45.28 while VRNA 8-day exponential moving average is 42.01, which is a Buy signal.
  • The stock price of VRNA is 45.28 while Verona Pharma PLC 20-day EMA is 40.56, which makes it a Buy.
  • Verona Pharma PLC 50-day exponential moving average is 37.61 while VRNA share price is 45.28, making it a Buy technically.
  • VRNA stock price is 45.28 and Verona Pharma PLC 200-day simple moving average is 27.82, creating a Buy signal.

Fundamental Analysis of Verona Pharma PLC

Is Verona Pharma PLC a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.73 per share, and an increase next year of $1.40 per share.

Technical Analysis of Verona Pharma PLC

Should I short Verona Pharma PLC stock?

* Verona Pharma PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.